Presentation ESC 2013 Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI):Results from the Real-World PARIS Registry Presenter: 32040|Roxana Mehran September 01, 2013
News Conference News ESC 2013 Length of DAPT, Reasons for Discontinuation Have Disparate Effects Yael L. Maxwell September 01, 2013